One of our most significant works thus far.
Immunomodulation by juglone alleviates acute graft‐versus‐host disease without compromising the graft‐versus‐leukaemia activity in mice - Gohil - British Journal of Pharmacology - Wiley Online Library https://t.co/z3tYdNMjau
Our earlier study identified sig covariate effect of CrCl on PEM clearance (J Clin Pharmacol. 2019;59(9):1216-24). Went on to test the effect of ADME gene polymorphisms, importantly SLC19A1. Interestingly ADME SNPS do not affect PEM PK. @DrSharathKumar6@srini_meen@VanitaNoronha
Looking forward to an exciting collab with @pumas_ai@vijay_ivaturi for the validation of Lyv algorithm for #TDM. Expect new trends for informed decisions on dose adjustments in #bmt and #oncology in the sub-continent.
Glad to share my first Ph.D. paper where we aimed to bring Withaferin-A one step closure to clinics by establishing it's toxicity and pharmacokinetics.
Kudos to @GotaVikram and the Clinical Pharmacology group from @ACTREC_TMC to achieve this milestone.
https://t.co/ho4Z8xBdmQ
Safety, toxicity and pharmacokinetic assessment of oral Withaferin-A i... https://t.co/aMDz10IgMa
Established the safety of Withaferin-A administered in its pure form. A milestone in the systematic development of WA as immunomodulator @akchichra@lingarajnayak@ministryofayush